Arabic Arabic English English French French German German
dark

Laboratory test aimed at distinguishing breast cancer from benign tumors

A novel laboratory test in development by researchers at the Johns Hopkins Kimmel Cancer Center may be used to help quickly distinguish breast cancer from benign disease. The breast cancer detection assay (BCDA) examines cells from enlarged lymph nodes in the armpit adjacent to a breast and finds chemical markers that indicate metastatic breast cancer or a benign condition, such as an infection. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

High demand for at-home COVID tests could hamper supply

Next Post

Delivery for hospitalized pregnant women improves recovery outcome, study finds

Related Posts
Total
0
Share